Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate

Abstract

Listen

Translate article

Journal of Mass SpectrometryVolume 40, Issue 8 p. 1109-1109 JMS Letter Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate Aimee E. Belanger, Corresponding Author Aimee E. Belanger Elanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USAElanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USA.===Search for more papers by this authorThomas R. Shryock, Thomas R. Shryock Elanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USASearch for more papers by this author Aimee E. Belanger, Corresponding Author Aimee E. Belanger Elanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USAElanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USA.===Search for more papers by this authorThomas R. Shryock, Thomas R. Shryock Elanco Animal Health, 2001 West Main Street, Greenfield, Indiana, 46140, USASearch for more papers by this author First published: 22 July 2005 https://doi.org/10.1002/jms.889Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume40, Issue8August 2005Pages 1109-1109 RelatedInformation